Susan M De Santi

Biosketch / Results /

Susan De Santi

Adjunct Associate Professor, Department of Psychiatry

Contact Info

212/263-5699
Susan.DeSanti@nyumc.org

Research Keywords

Brain imaging and cognition and the early diagnosis of cognitive impairment and Alzheimer's disease

Imaging Alzheimer's Disease: The Evolution of Biomarkers
de Leon, MJ; Glodzik, L; Mosconi, L; Osorio, R; Kamer, A; De Santi, S; Shulman, M; Li, Y; Tsui, W; Butler, T; Okamura, N; Rusinek, H. Imaging Alzheimer's Disease: The Evolution of Biomarkers IN: Brain Mapping: An Encyclopedic Reference. . p.619-623 (1842822)

Assessing cognition and function in Alzheimer's disease clinical trials: Do we have the right tools?
Snyder, Peter J; Kahle-Wrobleski, Kristin; Brannan, Stephen; Miller, David S; Schindler, Rachel J; DeSanti, Susan; Ryan, J Michael; Morrison, Glenn; Grundman, Michael; Chandler, Julie; Caselli, Richard J; Isaac, Maria; Bain, Lisa; Carrillo, Maria C. Assessing cognition and function in Alzheimer's disease clinical trials: Do we have the right tools?. Alzheimer's & dementia. 2014 Nov;10(6):853-860 (1370752)

Beyond amyloid: getting real about nonamyloid targets in Alzheimer's disease
Herrup, Karl; Carrillo, Maria C; Schenk, Dale; Cacace, Angela; Desanti, Susan; Fremeau, Robert; Bhat, Ratan; Glicksman, Marcie; May, Patrick; Swerdlow, Russell; Van Eldik, Linda J; Bain, Lisa J; Budd, Samantha. Beyond amyloid: getting real about nonamyloid targets in Alzheimer's disease [Meeting Abstract]. Alzheimer's & dementia. 2013 Jul;9(4):452-458.e1 (960132)

A preliminary, randomized, double-blind, placebo-controlled trial of l-carnosine to improve cognition in schizophrenia
Chengappa, K N Roy; Turkin, Scott R; Desanti, Susan; Bowie, Christopher R; Brar, Jaspreet S; Schlicht, Patricia J; Murphy, Sherry L; Hetrick, Michelle L; Bilder, Robert; Fleet, David. A preliminary, randomized, double-blind, placebo-controlled trial of l-carnosine to improve cognition in schizophrenia. Schizophrenia research. 2012 Dec;142(1-3):145-152 (203392)

Alzheimer's disease markers, hypertension, and gray matter damage in normal elderly
Glodzik L; Mosconi L; Tsui W; de Santi S; Zinkowski R; Pirraglia E; Rich KE; McHugh P; Li Y; Williams S; Ali F; Zetterberg H; Blennow K; Mehta P; de Leon MJ. Alzheimer's disease markers, hypertension, and gray matter damage in normal elderly. Neurobiology of aging. 2012 Jul;33(7):1215-1227 # (140516)